Efficacy assessment of treatment of patients with stage III primary open-angle glaucoma using a combined method (phosphene electrical stimulation and photomyostimulation)
DOI:
https://doi.org/10.31288/oftalmolzh20173914Keywords:
primary open-angle glaucoma, treatment, phosphene electric stimulation, photomyostimulationAbstract
The purpose: to assess the efficacy of a combined method, including phosphene electric stimulation (FES) and photomyostimulation, in treatment of patients with stage III primary open-angle glaucoma (POAG) with compensated IOP.
Material and Methods. Twenty-two eyes (22 patients) with stage III POAG with drug-compensated IOP were studied. The combined method consisted of a 10-minute FES session and a 10-minute photomyostimulation session. A patient had a 20-minute rest between the sessions. The treatment course included the10 sessions. To perform the FES session, a current value was specified in each certain case depending on a baseline phosphene threshold of electric sensivity (PTES). Photostimulation was carried out with impulse movement frequency (IMF), optimal to a patient, in a chaotic mode under scotopic conditions.
Results. The treatment resulted in the improvement of the functional mobility of the oculomotor system (the values of the IMX index significantly increased in all three modes). The functional activity of the visual system increased: PTES decreased by 21.4%, PhCFFF in the 1.5 and 3.0 modes increased by 21.6% and 18.1%, respectively. The mean deviation of light sensitivity decreased by 14.6% and the mean retinal light sensitivity according to all MS threshold values increased by 17.9 % with enlarged summarized visual field by14.8%. The method proposed had a positive effect for ocular hemodynamics. Thus, the facility of aqueous outflow increased by 29.4%, the Ро/С coefficient decreased by 27.1% and the rate of aqueous flow increased by 31.1%
Conclusion. The proposed method of treatment can be included in the complex of curative measures for the patients with stage III POAG in order to increase the functional activity of the visual system and to improve the patients’ quality of life.
References
Ponomarchuk VS, Degtiarenko TV, Chaura AG. [Mechanism of realization of curative effect using phosphene electric stimulation]. Neirofisiologiia. 1998; 30(6):519-23. Ukrainian. https://doi.org/10.1007/BF03027698
Putienko VA, Ponomarchuk VS. Results of phosphene electrostimulation treatment of patients with primary open-angle glaucoma J.ophthalmol.(Ukraine).2016;5:44-6. https://doi.org/10.31288/oftalmolzh201654446
Putienko VA, Ponomarchuk VS. Use of photomyostimulation method in treatment of patients with advanced primary open angle glaucoma. J.ophthalmol.(Ukraine).2017;2:33-7. https://doi.org/10.31288/oftalmolzh201723337
Chaura AG. [Physiological mechanisms of realization of effect of visual system electric stimulation]. Thesis for Cand. of Sc. (Biol.). Odessa;2009. 170p. Ukrainian.
Hood DC, Raza AS, De Moraes CGV. Initial arcuate defects within the central 10 degrees in glaucoma. Invest Ophthalmol Vis Sci. 2011;52:940-6. https://doi.org/10.1167/iovs.10-5803
Kaushik S, Pandav SS, Ram J. Neuroprotection in glaucoma. J. Postgrad Med. 2003;49(1):90. https://doi.org/10.4103/0022-3859.917
Kerrigan Baumrind L, Quigley H, Pease M et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-8.
Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82(11):887-8.
Quigley HA. Glaucoma. Lancet. 2011; 377(9774):1367-77. https://doi.org/10.1016/S0140-6736(10)61423-7
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020.Br. J. Ophthalmol. 2006;90(3):262-7. https://doi.org/10.1136/bjo.2005.081224
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 В. А. Путиенко, В. С. Пономарчук
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
